Interius is an early-stage biotechnology company expanding the potential of cell and gene therapy by developing next-generation delivery technology based on inventions from the laboratory of Dr. Saar Gill at the University of Pennsylvania.
View Top Employees from Interius BioTherapeuticsWebsite | https://interiusbio.com/ |
Employees | 53 (50 on RocketReach) |
Founded | 2019 |
Address | 3401 Grays Ferry Ave Building 200, Suite 300, Philadelphia, Pennsylvania 19146, US |
Industry | Biotechnology Research, Biotechnology, Other Pharmaceuticals and Biotechnology |
Looking for a particular Interius BioTherapeutics employee's phone or email?
Philip Johnson is the CEO of Interius BioTherapeutics.
50 people are employed at Interius BioTherapeutics.
Interius BioTherapeutics is based in Philadelphia, Pennsylvania.